| 000 | 01165cam a22002655i 4500 | ||
|---|---|---|---|
| 003 | EG-CaNGU | ||
| 005 | 20240221100132.0 | ||
| 008 | 220306s2019 flua frb 001 0 eng d | ||
| 020 | _a9781420084726 | ||
| 040 |
_aDNLM/DLC _cDLC _dBTCTA _dBAKER _dYDXCP _dNLM _dC#P _dMUQ _dUKM _dEG-CaNGU _dDLC _beng _erda |
||
| 082 | 0 | 4 |
_a615.19 _bPRE _223 |
| 245 | 0 | 0 | _aPreclinical drug development / |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_aBoca Raton, Florida : _bTaylor & Francis Group, CRC Press, _c2019. |
|
| 300 |
_a359 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 490 | 0 |
_aDrugs and the pharmaceutical sciences ; _v187 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 7 |
_aDrug development. _2NGU-sh _93329 |
|
| 700 | 1 |
_aRogge, Mark C., _eeditor. _94126 |
|
| 700 | 1 |
_aTaft, David R., _eeditor. _94127 |
|
| 999 |
_c1268 _d1268 |
||